The U.S. Food and Drug Administration said Ozempic and Wegovy, the popular GLP-1 drugs for diabetes and weight loss, are no ...
The FDA has announced that the shortage of Wegovy and Ozempic, medications used for weight loss and diabetes management, is ...
Yosemite Drug in the Coarsegold Historic Village, whose clients are generally 60 or older, announced it will close up shop ...
Debate over whether or not the Affordable Care Act, commonly known as Obamacare, worked and how President Trump's executive ...
President Donald Trump in a sometimes tense meeting Friday with the nation’s governors pressed them to enact the death ...
The Maryland House of Delegates has voted overwhelmingly to allow a state board to extend its mandate for lowering ...
Narrow-moat-rated Repligen is a leading provider of bioprocessing solutions for companies that manufacture biologic drugs. Its business lines include advanced filtration and fluid management systems ...
The FDA has now resolved the shortages of Novo Nordisk’s and Eli Lilly’s blockbuster weight-loss drugs, which could spell the ...
An insurance trust utilized by 80 school districts in the state, mostly in Southern Illinois, has fallen $7 million in the ...
The Food and Drug Administration on Friday announced that semaglutide, the active ingredient in weight loss drugs Ozempic and ...
Lenacapavir, a twice yearly injection that prevents HIV transmission, was named the breakthrough medicine of 2024. But ...
Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results